Corcept Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Corcept Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Corcept Therapeutics Inc
Rating: 1.902277625
Author: Trendlyne DVM scores

Slowing Down Stock

about

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The ...

37.42 -0.08 (-0.21%)

68.11% Fall from 52W High

174.8K

XNAS Volume

XNAS 12 Jan, 2026 10:16 AM (EST)

Medium Financial Strength

44.4 / 100

Mid Valuation

38.3 / 100

Technically Bearish

25.0 / 100

Slowing Down Stock These stocks have medium financials and valuations, but weak momentum indicating decreasing investor interest View Similar Embed DVM

1Yr Price target upside is 143%

5 analysts

Corcept Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Corcept Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The ...

68.11% Fall from 52W High

SWOT Analysis

Corcept Therapeutics Inc Live Price Chart